Human Parainfluenza Virus Type 2 V Protein Modulates Iron Homeostasis.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
24 02 2021
Historique:
received: 23 09 2020
accepted: 15 12 2020
pubmed: 8 1 2021
medline: 6 5 2021
entrez: 7 1 2021
Statut: epublish

Résumé

Intracellular iron concentration is tightly controlled for cell viability. It is known to affect the growth of several viruses, but the molecular mechanisms are not well understood. We found that iron chelators inhibit growth of human parainfluenza virus type 2 (hPIV-2). Furthermore, infection with hPIV-2 alters ferritin localization from granules to a homogenous distribution within cytoplasm of iron-stimulated cells. The V protein of hPIV-2 interacts with ferritin heavy chain 1 (FTH1), a ferritin subunit. It also binds to nuclear receptor coactivator 4 (NCOA4), which mediates autophagic degradation of ferritin, so-called ferritinophagy. V protein consequently interferes with interaction between FTH1 and NCOA4. hPIV-2 growth is inhibited in FTH1 knockdown cell line where severe hPIV-2-induced apoptosis is shown. In contrast, NCOA4 knockdown results in the promotion of hPIV-2 growth and limited apoptosis. Our data collectively suggest that hPIV-2 V protein inhibits FTH1-NCOA4 interaction and subsequent ferritinophagy. This iron homeostasis modulation allows infected cells to avoid apoptotic cell death, resulting in effective growth of hPIV-2.

Identifiants

pubmed: 33408172
pii: JVI.01861-20
doi: 10.1128/JVI.01861-20
pmc: PMC8094939
pii:
doi:

Substances chimiques

NCOA4 protein, human 0
Nuclear Receptor Coactivators 0
Viral Structural Proteins 0
Ferritins 9007-73-2
Iron E1UOL152H7
FTH1 protein, human EC 1.-
Oxidoreductases EC 1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 American Society for Microbiology.

Références

Gastroenterology. 2010 Jun;138(7):2509-18, 2518.e1
pubmed: 20230822
J Virol. 2013 Jul;87(14):7966-76
pubmed: 23678181
Front Microbiol. 2020 Apr 30;11:803
pubmed: 32425917
Biometals. 2017 Aug;30(4):565-574
pubmed: 28612172
J Gen Virol. 2016 Mar;97(3):561-570
pubmed: 26675672
J Virol. 2012 Apr;86(7):3411-21
pubmed: 22301134
J Virol. 2018 Jun 13;92(13):
pubmed: 29695420
Virol J. 2017 Jun 5;14(1):103
pubmed: 28583206
J Gen Virol. 1997 Jun;78 ( Pt 6):1303-8
pubmed: 9191922
J Gen Virol. 2011 Sep;92(Pt 9):2072-2081
pubmed: 21593278
Apoptosis. 2000 Nov;5(5):415-8
pubmed: 11256882
Med Microbiol Immunol. 2018 Apr;207(2):141-150
pubmed: 29374787
J Virol. 2005 Jul;79(13):8591-601
pubmed: 15956600
Biochim Biophys Acta. 2009 Jul;1790(7):589-99
pubmed: 18929623
Nature. 2014 May 1;509(7498):105-9
pubmed: 24695223
Blood. 2002 May 15;99(10):3505-16
pubmed: 11986201
Cell. 2017 Jan 26;168(3):344-361
pubmed: 28129536
J Biol Chem. 1984 Dec 10;259(23):14354-6
pubmed: 6094553
Biochemistry. 2012 Jul 24;51(29):5705-24
pubmed: 22703180
J Virol. 2018 Mar 28;92(8):
pubmed: 29386287
Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17264-9
pubmed: 15563593
FEBS Lett. 2006 Oct 16;580(24):5635-40
pubmed: 16989814
J Gen Virol. 2018 Apr;99(4):501-511
pubmed: 29485395
Virology. 2019 Jul;533:108-114
pubmed: 31150988
Virology. 2018 Nov;524:90-96
pubmed: 30165310
J Gen Virol. 1996 Oct;77 ( Pt 10):2457-63
pubmed: 8887478
J Infect Dis. 2000 Feb;181(2):484-90
pubmed: 10669330
J Neurochem. 2008 Aug;106(3):1298-313
pubmed: 18485102
Elife. 2015 Oct 05;4:
pubmed: 26436293
J Virol. 2016 Sep 29;90(20):9394-405
pubmed: 27512058
Virology. 2002 Aug 15;300(1):92-9
pubmed: 12202209
Virology. 2007 May 25;362(1):85-98
pubmed: 17250865
Virology. 1990 Jul;177(1):116-23
pubmed: 2162103

Auteurs

Keisuke Ohta (K)

Department of Microbiology, School of Medicine, Wakayama Medical University.

Naoki Saka (N)

Department of Microbiology, School of Medicine, Wakayama Medical University.

Machiko Nishio (M)

Department of Microbiology, School of Medicine, Wakayama Medical University mnishio@wakayama-med.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH